Next Article in Journal
Resistance-Related l-Pyroglutamic Acid Affects the Biosynthesis of Trichothecenes and Phenylpropanoids by F. graminearum Sensu Stricto
Next Article in Special Issue
Chlorotoxin—A Multimodal Imaging Platform for Targeting Glioma Tumors
Previous Article in Journal
First Report of Okadaic Acid and Pectenotoxins in Individual Cells of Dinophysis and in Scallops Argopecten purpuratus from Perú
Previous Article in Special Issue
Pharmacokinetics of Toxin-Derived Peptide Drugs
 
 
Review

The Fever Tree: from Malaria to Neurological Diseases

Institute for Drug Research, School of Pharmacy, The Hebrew University of Jerusalem, Jerusalem 91120, Israel
Toxins 2018, 10(12), 491; https://doi.org/10.3390/toxins10120491
Received: 19 October 2018 / Revised: 14 November 2018 / Accepted: 15 November 2018 / Published: 23 November 2018
(This article belongs to the Special Issue From Toxins to Drugs)
This article describes the discovery and use of the South American cinchona bark and its main therapeutic (and toxic) alkaloids, quinine and quinidine. Since the introduction of cinchona to Europe in the 17th century, it played a role in treating emperors and peasants and was central to colonialism and wars. Over those 400 years, the medical use of cinchona alkaloids has evolved from bark extracts to chemical synthesis and controlled clinical trials. At the present time, the use of quinine and quinidine has declined, to a large extent due to their toxicity. However, quinine is still being prescribed in resource-limited settings, in severe malaria, and in pregnant women, and quinidine made a limited comeback in the treatment of several cardiac and neurological syndromes. In addition, the article presents more recent studies which improved our understanding of cinchona alkaloids’ pharmacology. The knowledge gained through these studies will hopefully lead to a wider use of these drugs in precision medicine and to design of new generation, safer quinine and quinidine derivatives. View Full-Text
Keywords: quinine; quinidine; cinchona; malaria; atrial fibrillation; Brugada syndrome; prolonged QT syndrome; restless leg syndrome; Alzheimer’s disease; epilepsy quinine; quinidine; cinchona; malaria; atrial fibrillation; Brugada syndrome; prolonged QT syndrome; restless leg syndrome; Alzheimer’s disease; epilepsy
Show Figures

Graphical abstract

MDPI and ACS Style

Eyal, S. The Fever Tree: from Malaria to Neurological Diseases. Toxins 2018, 10, 491. https://doi.org/10.3390/toxins10120491

AMA Style

Eyal S. The Fever Tree: from Malaria to Neurological Diseases. Toxins. 2018; 10(12):491. https://doi.org/10.3390/toxins10120491

Chicago/Turabian Style

Eyal, Sara. 2018. "The Fever Tree: from Malaria to Neurological Diseases" Toxins 10, no. 12: 491. https://doi.org/10.3390/toxins10120491

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop